Article: | MedLuna.com

Overview

Journal Adv Lab Med

Publisher De Gruyter

Specialty Biochemistry

Date 2023 Jun 26

PMID 37360613

Authors

Cristina A Lopez Rodriguez

Marc Boigues Pons

Bibiana Quirant Sanchez

Aina Teniente Serra

Joan Climent Marti

Eva Ma Martinez Caceres

Affiliations

Soon will be listed here.

References

Shanmugaraj B, Siriwattananon K, Wangkanont K, Phoolcharoen W . Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). Asian Pac J Allergy Immunol. 2020; 38(1):10-18. DOI: 10.12932/AP-200220-0773. View

Long Q, Liu B, Deng H, Wu G, Deng K, Chen Y . Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020; 26(6):845-848. DOI: 10.1038/s41591-020-0897-1. View

Zhao J, Zhao J, Mangalam A, Channappanavar R, Fett C, Meyerholz D . Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses. Immunity. 2016; 44(6):1379-91. PMC: 4917442. DOI: 10.1016/j.immuni.2016.05.006. View

Le T, Andreadakis Z, Kumar A, Roman R, Tollefsen S, Saville M . The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020; 19(5):305-306. DOI: 10.1038/d41573-020-00073-5. View

Monteagudo L, Boothby A, Gertner E . Continuous Intravenous Anakinra Infusion to Calm the Cytokine Storm in Macrophage Activation Syndrome. ACR Open Rheumatol. 2020; 2(5):276-282. PMC: 7231518. DOI: 10.1002/acr2.11135. View

Li C, Wu H, Yan H, Ma S, Wang L, Zhang M . T cell responses to whole SARS coronavirus in humans. J Immunol. 2008; 181(8):5490-500. PMC: 2683413. DOI: 10.4049/jimmunol.181.8.5490. View

Li Z, Yi Y, Luo X, Xiong N, Liu Y, Li S . Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. J Med Virol. 2020; 92(9):1518-1524. PMC: 7228300. DOI: 10.1002/jmv.25727. View

Zheng J . SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat. Int J Biol Sci. 2020; 16(10):1678-1685. PMC: 7098030. DOI: 10.7150/ijbs.45053. View

Siddiqi H, Mehra M . COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020; 39(5):405-407. PMC: 7118652. DOI: 10.1016/j.healun.2020.03.012. View

10.

Zhang W, Du R, Li B, Zheng X, Yang X, Hu B . Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020; 9(1):386-389. PMC: 7048229. DOI: 10.1080/22221751.2020.1729071. View

11.

Hu W, Yen Y, Singh S, Kao C, Wu-Hsieh B . SARS-CoV regulates immune function-related gene expression in human monocytic cells. Viral Immunol. 2012; 25(4):277-88. PMC: 3413073. DOI: 10.1089/vim.2011.0099. View

12.

Loeffelholz M, Tang Y . Laboratory diagnosis of emerging human coronavirus infections - the state of the art. Emerg Microbes Infect. 2020; 9(1):747-756. PMC: 7172701. DOI: 10.1080/22221751.2020.1745095. View

13.

Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y . Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019. Clin Infect Dis. 2020; 71(16):2027-2034. PMC: 7184337. DOI: 10.1093/cid/ciaa344. View

14.

Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H . Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020; 130(5):2620-2629. PMC: 7190990. DOI: 10.1172/JCI137244. View

15.

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

16.

Xu F, Wen Z, Shi X, Fan J . Inflammasome in the Pathogenesis of Pulmonary Diseases. Exp Suppl. 2018; 108:111-151. PMC: 7123416. DOI: 10.1007/978-3-319-89390-7_6. View

17.

Wang F, Nie J, Wang H, Zhao Q, Xiong Y, Deng L . Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia. J Infect Dis. 2020; 221(11):1762-1769. PMC: 7184346. DOI: 10.1093/infdis/jiaa150. View

18.

Lin L, Lu L, Cao W, Li T . Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect. 2020; 9(1):727-732. PMC: 7170333. DOI: 10.1080/22221751.2020.1746199. View

19.

Zhang C, Wu Z, Li J, Zhao H, Wang G . Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020; 55(5):105954. PMC: 7118634. DOI: 10.1016/j.ijantimicag.2020.105954. View

20.

Ng O, Chia A, Tan A, Jadi R, Leong H, Bertoletti A . Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection. Vaccine. 2016; 34(17):2008-14. PMC: 7115611. DOI: 10.1016/j.vaccine.2016.02.063. View